Unexplained weight loss (UWL), defined as a loss of more than 5% of the patient's body weight over a period of 6-12 months without a known cause, is a common yet challenging presentation in clinical practice. It can be an indicator of several underlying conditions, ranging from malignancies and endocrine disorders to psychiatric illnesses. This article aims to provide a comprehensive approach to evaluating and managing UWL.
The evaluation of UWL should be systematic and thorough. A detailed history, physical examination, and basic laboratory tests can identify a cause in about half of the cases. The history should focus on dietary intake, physical activity, changes in taste or smell, gastrointestinal symptoms, and psychosocial factors. The physical examination should include a comprehensive evaluation of all systems, with special attention to signs of malignancy, endocrine disorders, and malabsorption.
If the initial evaluation does not reveal a cause, further laboratory and imaging studies should be considered based on the patient's history and physical examination. Commonly used tests include complete blood count, metabolic panel, thyroid function tests, HIV testing, and imaging studies like a chest X-ray or abdominal ultrasound. Endoscopy and biopsy may be necessary in some cases.
Management of UWL depends on the underlying cause. If a specific disease is identified, treatment should be directed towards it. If no cause is found, the patient should be reassured and monitored closely for the development of new symptoms or signs. Nutritional support and psychological counseling may be beneficial in some cases.
Unexplained weight loss is a complex clinical problem that demands a comprehensive and systematic approach. While it can be a sign of serious underlying disease, a thorough evaluation often leads to the identification of a treatable cause. Close follow-up is crucial in cases where no cause is found, as new symptoms or signs may emerge over time.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation